
Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.
Pfizer's Bumpy Ride: One company that has been a lackluster investment in the past two years has been pharmaceutical giant Pfizer Inc. (NYSE:PFE).